— Know what they know.
Not Investment Advice
Also trades as: GMAB (NASDAQ) · $vol 127M · GMAB.CO (CPH) · $vol 55M · GE9.F (FSX) · $vol 0M

GNMSF Short Interest

Genmab A/S
1W: +21.9% 1M: +29.1% 3M: +56.5% YTD: +42.5% 1Y: +50.6% 3Y: +51.1% 5Y: +0.1%
$439.05
-8.50 (-1.90%)
After Hours: $441.73 (+2.68, +0.61%)
Weekly Expected Move ±10.1%
$357 $402 $448 $493 $538
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 76 · $27.0B mcap · 56M float · 0.0022% daily turnover · Short 43% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $6.49 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.48B.
Distance to default 7.47 (Merton model): prices to 2026-10-23, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-23
1.9%
Short Ratio
of total volume
47.6%
20-Day Avg
54.9%
50-Day Avg
▼ Falling
5-Day Trend
0.0M
Short Volume
0.0M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-23
ExchangeShort VolumeTotal VolumeShort %
O 233 12,320 1.9%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms